Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents By Reuters



© Reuters. FILE PHOTO: Test tubes are seen in front of displayed Pfizer and Biontech logos in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration


(Reuters) – Pfizer Inc (NYSE:) and its German partner BioNTech SE (NASDAQ:) fired back on Monday at a patent lawsuit filed by Moderna (NASDAQ:) Inc in Boston federal court over their rival COVID-19 vaccines, seeking a dismissal of the lawsuit and a court order that they did not infringe Moderna’s patents.

Source link

Leave A Reply

Your email address will not be published.